FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3802411000001103: Akineton 2mg tablets (Abbott Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17798101000001115 Akineton 2mg tablets (Abbott Laboratories Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17798201000001110 Akineton 2mg tablets (Abbott Laboratories Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Akineton 2mg tablets (Abbott Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Is a Product containing precisely biperiden hydrochloride 2 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has active ingredient Biperiden hydrochloride false Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has active ingredient Antiparkinsonian agent false Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Is a Akineton true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has specific active ingredient Biperiden hydrochloride true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Akineton 2mg tablets (Abbott Laboratories Ltd) 100 tablet Is pack of False Akineton 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier
Akineton 2mg tablets (Abbott Laboratories Ltd) 100 tablet Has AMP True Akineton 2mg tablets (Abbott Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start